Alphinity Investment Management Pty Ltd Sells 108,992 Shares of Intuitive Surgical, Inc. $ISRG

Alphinity Investment Management Pty Ltd reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 770,716 shares of the medical equipment provider’s stock after selling 108,992 shares during the period. Intuitive Surgical accounts for about 3.4% of Alphinity Investment Management Pty Ltd’s portfolio, making the stock its 18th largest holding. Alphinity Investment Management Pty Ltd owned about 0.21% of Intuitive Surgical worth $344,687,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Brighton Jones LLC grew its holdings in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the period. Sivia Capital Partners LLC raised its stake in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the period. Leo Wealth LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $209,000. Monument Capital Management bought a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $245,000. Finally, JB Capital LLC boosted its stake in shares of Intuitive Surgical by 11.4% during the 2nd quarter. JB Capital LLC now owns 459 shares of the medical equipment provider’s stock worth $249,000 after acquiring an additional 47 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Truist Financial increased their price target on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research note on Thursday, December 18th. The Goldman Sachs Group reissued a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn upped their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $488.15 on Friday. The company has a market cap of $173.36 billion, a price-to-earnings ratio of 61.87, a PEG ratio of 3.79 and a beta of 1.65. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The stock has a fifty day moving average price of $549.63 and a 200-day moving average price of $510.54.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.21 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. This trade represents a 37.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 73,616 shares of company stock worth $40,929,575. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.